Comparison 5. Phenobarbital versus lorazepam as first‐line ASM in clinically diagnosed neonatal seizures.
| Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
|---|---|---|---|---|
| 5.1 Proportion of infants who achieve seizure control after the first loading dose of ASM | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
| 5.2 Mortality before hospital discharge | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
| 5.3 Proportion of infants who develop sedation or drowsiness | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
| 5.4 Proportion of infants with persistent seizures and/or requiring ASM at discharge | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected |